Invokana is a Type 2 diabetes medication developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. These drugs are designed to help...
European Regulators Warn of Xeljanz Safety Risks
On May 17, 2019, the European Medicines Agency (EMA) announced an important recommendation concerning Xeljanz (tofacitinib). Due to concerns about blood clots in the lungs, doctors shouldn't prescribe the twice...
What to Expect From a Mesothelioma Mass Tort Lawsuit
Mesothelioma is a rare, aggressive form of cancer that has been linked primarily to asbestos exposure. It derives its name from mesothelium, the thin layer of tissue that covers internal organs. Mesothelioma can...